durvalumab,azacitidine,Magrolimab
astrazeneca,gilead
['durva', 'mds', 'aza ', 'durvalumab']
#eha22 #mdssm wiseman: durvalumab failed to show benefit (os was worse, not sig) with durva/aza vs aza. magro (anti-cd47) is showing deep responses with aza; survival data pending from enhance study. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)